Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Electronic Letters to:

Letters to the Editor:
Boban Abraham, Ijaz Fakhar, Anurag Tikaria, LaDonna Hocutt, Jim Marshall, Sundararaman Swaminathan, and Joshua A. Bornhorst
Reverse Pseudohyperkalemia in a Leukemic Patient
Clin Chem 2008; 54: 449-451 [Full text] [PDF]
*eLetters: Submit a response to this article

Electronic letters published:

[Read eLetter] Possible artefactual hyperkalemia
Christian P PERIER   (25 February 2008)

Possible artefactual hyperkalemia 25 February 2008
  Top
Christian P PERIER,
clinical chemist
Pôle de biologie CHU SAINT ETIENNE FRANCE

Send letter to journal:
Re: Possible artefactual hyperkalemia

christian.perier{at}chu-st-etienne.fr Christian P PERIER

Dear sir,

About the paper" Reverse pseudohyperkalemia in a leukemic patient", another explanatory hypothesis could be proposed in order to elucidate the initial reported hyperkalemia ( 10.7 mmol/L and 11.2 mmol/L): after therapy, hyperkalemia could be due to lysed white cells by cytotoxic drugs as a result of delayed separation of plasma from the cells (~ 60 min) in preparation for potassium testing.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the American Association for Clinical Chemistry.